Intrinsic Value of S&P & Nasdaq Contact Us

Goodness Growth Holdings, Inc. GDNSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
37/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.45
-0.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Goodness Growth Holdings, Inc. (GDNSF) .

Criteria proven by this page:

  • VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Analyst consensus target $0.45 (-0.5% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 37/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
37/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
63/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — GDNSF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.09
Book Value / Share$0.00
Revenue / Share$365.80
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$0.45 (-0.5%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.32 $4.26M $-108K -2.5%
2017 $-0.22 $10.87M $-83.97K -0.8%
2018 $-0.22 $18.46M $-139K -0.8%
2019 $-0.71 $29.96M $-57.48M -191.9%
2020 $-0.24 $49.21M $-22.94M -46.6%
2021 $-0.27 $54.45M $-33.69M -61.9%
2022 $-0.33 $74.63M $-42.46M -56.9%
2023 $-0.19 $88.13M $-25.55M -29%
2024 $-0.16 $99.38M $-28.01M -28.2%
2025 $-0.09 $268.77T $-53.32T -19.8%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message